APA (7th ed.) Citation

P, D., X, L., D, L., Y, M., M, N., Y, L., . . . X, X. PEAR1, PON1, CYP2C19, CYP1A2 and F2R Polymorphisms are Associated with MACE in Clopidogrel-Treated Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention. Dove Medical Press.

Chicago Style (17th ed.) Citation

P, Du, Li X, Li D, Ma Y, Ni M, Li Y, Li W, Wang A, and Xu X. PEAR1, PON1, CYP2C19, CYP1A2 and F2R Polymorphisms Are Associated with MACE in Clopidogrel-Treated Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention. Dove Medical Press.

MLA (9th ed.) Citation

P, Du, et al. PEAR1, PON1, CYP2C19, CYP1A2 and F2R Polymorphisms Are Associated with MACE in Clopidogrel-Treated Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention. Dove Medical Press.